A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of ALKS 7119 in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 02 Sep 2016
At a glance
- Drugs ALKS 7119 (Primary)
- Indications Agitation
- Focus Adverse reactions; Pharmacokinetics
- 02 Sep 2016 Planned initiation date changed from 1 Oct 2016 to 11 Jul 2016.
- 02 Sep 2016 Planned number of patients changed to 40.
- 29 Apr 2016 New trial record